Summary of Study ST003141

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001952. The data can be accessed directly via it's Project DOI: 10.21228/M8DD95 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST003141
Study Titleuntargeted metabolomic analysis of whole blood from AMX-treated and untreated mice
Study Summaryuntargeted metabolomic analysis of whole blood from AMX-treated and untreated mice
Institute
Brown University
Last NameBeekman
First NameChapman
Address171 Meeting Street, Providence, Rhode Island, 02912, USA
EmailChapman_Beekman@brown.edu
Phone4012071832
Submit Date2024-01-17
Analysis Type DetailLC-MS
Release Date2024-08-05
Release Version1
Chapman Beekman Chapman Beekman
https://dx.doi.org/10.21228/M8DD95
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001952
Project DOI:doi: 10.21228/M8DD95
Project Title:Spatial analysis of murine GI reveals role of small intestinal bile acid metabolism in amoxicillin-induced dysbiosis
Project Summary:Antibiotics cause collateral damage to resident microbes that is associated with various health risks. To-date, studies have largely focused on impacts of antibiotics on large intestinal and fecal microbiota. Here, we employ a GI-wide integrated multiomic approach to reveal that amoxicillin (AMX) treatment reduces overall bacterial abundance, bile salt hydrolase activity and unconjugated bile acids in the small intestine (SI). An accompanying loss of fatty acids and increase in acyl-carnitines in the large intestine corresponded with spatially-distinct expansions of proteobacteria. Parasutterella excrementihominis utilized fatty acid biosynthesis, becoming dominant in the SI while multiple Klebsiella species employed fatty acid oxidation during expansion in the large intestine. Depletion of bile acids and lipids may contribute to AMX-induced dysbiosis in the lower GI. To test this, we demonstrate that restoration of unconjugated bile acids can mitigate losses of commensals in the large intestine while also inhibiting the expansion of Proteobacteria during AMX treatment.
Institute:Brown University
Department:MMI
Laboratory:MMI, Belenky Lab
Last Name:Beekman
First Name:Chapman
Address:BMC 613, 171 Meeting Street, Providence RI 02912
Email:Chapman_Beekman@brown.edu
Phone:4012071832

Subject:

Subject ID:SU003258
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Treatment
SA340606CB80Amox
SA340607CB81Amox
SA340608CB73Amox
SA340609CB79Amox
SA340610CB74Amox
SA340611CB75Amox
SA340612CB84Control
SA340613CB77Control
SA340614CB83Control
SA340615CB82Control
SA340616CB78Control
SA340617CB76Control
Showing results 1 to 12 of 12

Collection:

Collection ID:CO003251
Collection Summary:Lumenal contents collected from multiple GI sites and immediately flash frozen
Sample Type:Blood (whole)

Treatment:

Treatment ID:TR003267
Treatment Summary:Mice were treated for 24h with amoxicillin/vehicle in drinking water
Treatment Compound:Amoxicillin
Treatment Route:oral

Sample Preparation:

Sampleprep ID:SP003265
Sampleprep Summary:Frozen GI contents were lyophilized and 10mg of dry contents were extracted twice in 300µL in (2:1) acetone and isopropanol. Samples were maintained on dry ice during extraction steps. Extracts were diluted 1:10 in a solution of 80% methanol in water. All solvents were LC-MS grade purchased from Fisher Scientific.

Combined analysis:

Analysis ID AN005154
Analysis type MS
Chromatography type None (Direct infusion)
Chromatography system none
Column none
MS Type ESI
MS instrument type QTOF
MS instrument name Agilent 6550 QTOF
Ion Mode NEGATIVE
Units ion counts

Chromatography:

Chromatography ID:CH003902
Instrument Name:none
Column Name:none
Column Temperature:na
Flow Gradient:none
Flow Rate:na
Solvent A:none
Solvent B:none
Chromatography Type:None (Direct infusion)

MS:

MS ID:MS004890
Analysis ID:AN005154
Instrument Name:Agilent 6550 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:A pooled study sample (pSS) was prepared by combining 5 µL of each sample. The pSS was injected every ten samples during data acquisition. Instrumental Analysis Metabolome profiles of the sample extracts were acquired using flow-injection mass spectrometry. The method described here is adapted from Fuhrer et al 2011. The instrumentation consisted of an Agilent 6550 iFunnel LC-MS Q-TOF mass spectrometer in tandem with an MPS3 autosampler (Gerstel) and an Agilent 1260 Infinity II quaternary pump. The running buffer was 60% isopropanol in water (v/v) with 1 mM ammonium fluoride. Hexakis (1H, 1H, 3H-tetrafluoropropoxy)-phosphazene) (Agilent) and 3-amino-1-propanesulfonic acid (HOT) (Sigma Aldrich) were added to the running buffer to serve as lockmasses. The isocratic flow rate was set to 0.150 mL/min. The instrument was run in 4GHz High Resolution, negative ionization mode. Mass spectra between 50 and 1,000 m/z were collected in profile mode. 5 µL of each sample were injected twice, consecutively, within 0.96 minutes to serve as technical replicates. The pooled study sample was injected periodically throughout the batch. Data Processing & Annotation Raw profile data were centroided, merged, and recalibrated using MATLAB software described by Fuhrer et al(doi/10.1021/ac201267k).
Ion Mode:NEGATIVE
  logo